17202-57-2Relevant articles and documents
Hepatitis C Virus Inhibitors
-
Paragraph 2317, (2015/02/25)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
The first synthesis of nitro-substituted cyclopropanes and spiropentanes via oxidation of the corresponding amino derivatives
Volkova, Yuliya A.,Ivanova, Olga A.,Budynina, Ekaterina M.,Revunov, Eugene V.,Averina, Elena B.
scheme or table, p. 2793 - 2796 (2009/09/28)
A novel approach to nitro-substituted cyclopropanes and spiropentanes via oxidation of the corresponding amines with dimethyldioxirane is reported. The method is used successfully for the preparation of a series of nitrocyclopropanes as well as for the first synthesis of 1,4-dinitrospiro[2.2]pentane.